Views & Analysis Pharma partners with African countries on chronic diseases An innovative programme is being rolled out across Kenya.
News Takeda preps for further acquisition Japanese firm has set money aside for emerging markets M&A.
Views & Analysis Going beyond CSR to reach ‘the two billion’ Impact of putting access to medicine at the core of pharma businesses.
Views & Analysis Disrupting healthcare: 4 lessons from emerging markets Ingenious low-cost solutions to healthcare problems in the developing world can inspire change in global healthcare.
News GSK settles US bribery probe for $20m Actions of Chinese subsidiaries violated US bribery laws, says SEC.
Views & Analysis Healthcare opportunities in Latin America This first article in a three-part series sets the scene for healthcare trends in Latin America and covers the impact of currency devaluations, corruption and public-private partnerships (PPPs)
